Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3406]
News [7767]
Articles [63]
Editorials [9]
Conferences [207]
elearning [49]
Exciting new developments in the treatment of multicentric Castleman disease
Prof Nikhil Munshi - Harvard Medical School, Massachussets, USA and Dr Raymond...
Exciting new developments in the treatment of multicentric Castleman disease ( Prof Nikhil Munshi - Harvard Medical School, Massachussets, USA and Dr Raymond Wong - The Chinese University of Hong Kong )
19 Dec 2013
New therapy aspects for myeloid chronic lymphoma
Dr Simon Rule, Prof Martin Dreyling, Prof Olivier Hermine
New therapy aspects for myeloid chronic lymphoma ( Dr Simon Rule, Prof Martin Dreyling, Prof Olivier Hermine )
19 Dec 2013
Careers in translational research
Dr Geoffry Shapiro - Dana Farber Cancer Institute, Boston, USA
Careers in translational research ( Dr Geoffry Shapiro - Dana Farber Cancer Institute, Boston, USA )
19 Dec 2013
New agents in CLL
Dr Jacqueline Barrientos - LIJ Medical Center, New York, USA
New agents in CLL ( Dr Jacqueline Barrientos - LIJ Medical Center, New York, USA )
13 Dec 2013
BETH study: highly effective treatment option for patients with HER2 breast...
Dr Dennis Slamon - University of California, Los Angeles
BETH study: highly effective treatment option for patients with HER2 breast cancer ( Dr Dennis Slamon - University of California, Los Angeles )
12 Dec 2013
Initial phase III results of the first trial in newly diagnosed multiple myeloma
Dr Thierry Facon - Centre Hospitalier Régional Universitaire de Lille, France
Initial phase III results of the first trial in newly diagnosed multiple myeloma ( Dr Thierry Facon - Centre Hospitalier Régional Universitaire de Lille, France )
10 Dec 2013
Lenalidomide promotes CRBN-mediated ubiquitination and degradation of IKZF1 and...
Dr Jan Krönke - Brigham and Women's Hospital, Boston, USA
Lenalidomide promotes CRBN-mediated ubiquitination and degradation of IKZF1 and IKZF3 ( Dr Jan Krönke - Brigham and Women's Hospital, Boston, USA )
8 Dec 2013
Chimeric antigen receptor produces complete responses and long-term persistence...
Dr. Stephen A. Grupp - University of Pennsylvania, Philadelphia, USA
Chimeric antigen receptor produces complete responses and long-term persistence in children and adults relapsed, refractory ALL ( Dr. Stephen A. Grupp - University of Pennsylvania, Philadelphia, USA )
8 Dec 2013
Study of the efficacy and safety of siltuximab, an anti-interleukin-6...
Dr Raymond Wong - Chinese University of Hong Kong
Study of the efficacy and safety of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with multicentric Castleman’s disease ( Dr Raymond Wong - Chinese University of Hong Kong )
8 Dec 2013
In vitro and in vivo assessment of anfibatide, a novel glycoprotein ib...
Dr Neyu Ni - University of Toronto, Canada
In vitro and in vivo assessment of anfibatide, a novel glycoprotein ib antagonist ( Dr Neyu Ni - University of Toronto, Canada )
8 Dec 2013
Results from the randomised phase III Children’s Oncology Group (COG) trial...
Dr Alan Gamis - Children’s Mercy Hospital, Kansas City, USA
Results from the randomised phase III Children’s Oncology Group (COG) trial, AAML0531 ( Dr Alan Gamis - Children’s Mercy Hospital, Kansas City, USA )
8 Dec 2013
Final stage II results of the CLL11 trial
Dr Valentin Goede - University of Cologne, Germany
Final stage II results of the CLL11 trial ( Dr Valentin Goede - University of Cologne, Germany )
8 Dec 2013

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation